{ }
001122334455554433221100
001122334455554433221100

ubs lowers price target for tandem diabetes care to thirty five dollars

UBS has lowered its price target on Tandem Diabetes Care to $35 from $40 while maintaining a neutral rating. The company specializes in advanced insulin delivery systems, including the Tandem Mobi and t:slim X2 insulin pumps, both featuring Control-IQ technology for automated insulin delivery. These pumps are compatible with various infusion sets and can be updated via software, enhancing user experience and glycemic control.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.